Elevance Health (ELV) Cash from Financing Activities (2010 - 2026)

Elevance Health (ELV) has reported Cash from Financing Activities for 17 consecutive years, with -$1.5 billion the latest figure, recorded in Q2 2026.

• In Q2 2026, Cash from Financing Activities fell 385.06% year-over-year to -$1.5 billion; the TTM figure through Jun 2026 stood at -$3.5 billion (down 104.76% YoY), while the FY2025 annual figure was -$1.7 billion, down 245.68% from the prior year.
• Cash from Financing Activities grew to -$1.5 billion in Q2 2026 per ELV's latest filing, from -$2.5 billion in the prior quarter.
• Across five years, Cash from Financing Activities topped out at $1.4 billion in Q4 2024 and bottomed at -$2.5 billion in Q1 2026.
• Historically, Cash from Financing Activities has averaged -$512.3 million across 5 years, with a median of -$351.0 million in 2023.
• Annual changes were most pronounced in 2024 — Cash from Financing Activities surged 457.36% — and 2025, when it plunged 6065.62%.
• Elevance Health's Cash from Financing Activities stood at -$258.0 million in 2022, then slumped by 52.71% to -$394.0 million in 2023, then soared by 457.36% to $1.4 billion in 2024, then tumbled by 83.24% to $236.0 million in 2025, then tumbled by 733.05% to -$1.5 billion in 2026.
• Business Quant data shows ELV's Cash from Financing Activities at -$1.5 billion in Q2 2026, -$2.5 billion in Q1 2026, and $236.0 million in Q4 2025.